# A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines

> **NCT04821089** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Ipsen** · enrollment: 727 (estimated)

## Conditions studied

- Moderate to Severe Upper Facial Lines

## Interventions

- **BIOLOGICAL:** IPN10200
- **BIOLOGICAL:** IPN10200 Placebo
- **BIOLOGICAL:** Dysport

## Key facts

- **NCT ID:** NCT04821089
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-04-06
- **Primary completion:** 2026-08-31
- **Final completion:** 2027-08-19
- **Target enrollment:** 727 (ESTIMATED)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04821089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04821089, "A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04821089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*